Researcher Profiles

Return to member profile

Edmund C. Lattime, PhD

Publications since 2011

de Vries, C. R. Kaufman, H. L. Lattime, E. C. Oncolytic viruses: focusing on the tumor microenvironment. Cancer Gene Ther, In process, . (PMID: 25721204)

de Vries, C. R. Monken, C. E. Lattime, E. C. The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy. Cancer Gene Ther, In process, . (PMID: 25633483)

DiPaola, R. S. Chen, Y. Bubley, G. J. Stein, M. N. Hahn, N. M. Carducci, M. A. Lattime, E. C. Gulley, J. L. Arlen, P. M. Butterfield, L. H. Wilding, G. A National Multicenter Phase 2 Study of Prostate-specific Antigen (PSA) Pox Virus Vaccine with Sequential Androgen Ablation Therapy in Patients with PSA Progression: ECOG 9802. Eur Urol, In process, . (PMID: 25533418)

Nikitczuk, K. P. Schloss, R. S. Yarmush, M. L. Lattime, E. C. PLGA-polymer encapsulating tumor antigen and CpG DNA administered into the tumor microenvironment elicits a systemic antigen-specific IFN-gamma response and enhances survival. J Cancer Ther, 4:280-290, . (PMID: 23741626, PMCID: PMC3670804)

Moloughney, J. G. Monken, C. E. Tao, H. Zhang, H. Thomas, J. D. Lattime, E. C. Jin, S. Vaccinia virus leads to ATG12-ATG3 conjugation and deficiency in autophagosome formation. Autophagy, 7:1434-1447, . (PMID: 22024753, PMCID: PMC3327614)